Heal Capital

Heal Capital is a venture capital firm that invests in technology-driven startups redefining healthcare. They focus on providing capital and access to the healthcare system to mission-driven founders. Their investment strategy targets early-stage HealthTech startups across Europe, from Pre-Seed to Series A. They aim to back companies that are leveraging technology to improve various aspects of healthcare, likely including diagnostics, treatment, patient care, and healthcare operations. Given the focus on access to the healthcare system, they probably actively facilitate partnerships and integration opportunities for their portfolio companies with existing healthcare providers and institutions. Their portfolio highlights various areas in healthtech, from platforms that help patients navigate healthcare to advanced AI tools used in radiology and drug discovery. This indicates a diverse investment interest within the broader HealthTech landscape. The mention of exited companies suggests a demonstrated ability to successfully guide startups to exit events. Heal Capital invests between €1-5m, allowing them to take meaningful stakes in companies at the seed and series A stage. They are likely to play an active role in the companies they invest in, using their expertise and network to accelerate growth.

HealthTech, digital health, AI in radiology, computer-brain-interface, virtual regulatory compliance, digital patient support, care tech, dermatology, AI-powered service provider for public sector contracts, home care, decision support for hemato-oncology labs, AI-driven symptom checker

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.